U.S. News & World Report |
New Drug Reduces Heart Attacks, but Is That Enough?
U.S. News & World Report Merck study: New type of cholesterol drug meant to prevent heart attacks, other complications did so. But was it enough?. Aug. 29, 2017, at 2:35 a.m.. MORE. LinkedIn · StumbleUpon · Google +; Cancel. New Drug Reduces Heart Attacks, but Is That Enough? Merck cholesterol drug cuts heart risk by 9 percent in study Anacetrapib reduces risk of serious cardiovascular events in high risk patients (REVEAL) Merck REVEALS a Slightly Positive CETP Inhibitor Trial |
from Health - Google News http://ift.tt/2vA20DA
EmoticonEmoticon